JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Rocket Pharmaceuticals
RCKT
$367M
| $1.22M | ﹤0.01% |
53,540
+43,791
| +449% | +$731K |
|
3552
Midland States Bancorp
MSBI
$698M
| $1.22M | ﹤0.01% |
42,044
+11,853
| +39% | +$326K |
|
3553
PUT
CNX Resources
CNX
$5.23B
| $1.22M | ﹤0.01% |
137,500
-200,000
| -59% | -$1.56M |
|
|
VRAY
3554
DELISTED
ViewRay, Inc.
VRAY
| $1.22M | ﹤0.01% |
288,229
+265,108
| +1,147% | +$857K |
|
3555
PUT
Medifast
MED
$128M
| $1.22M | ﹤0.01% |
+11,100
| New | +$1.07M |
|
3556
James River Group Holdings
JRVR
$200M
| $1.21M | ﹤0.01% |
29,462
+2,052
| +7% | +$80.6K |
|
|
BRFS
3557
DELISTED
BRF SA
BRFS
| $1.21M | ﹤0.01% |
138,907
-3,175,901
| -96% | -$27.4M |
|
|
CCF
3558
DELISTED
Chase Corporation
CCF
| $1.21M | ﹤0.01% |
10,192
+4,026
| +65% | +$467K |
|
3559
Orrstown Financial Services
ORRF
$855M
| $1.21M | ﹤0.01% |
53,358
+8,479
| +19% | +$187K |
|
|
CUTR
3560
DELISTED
Cutera, Inc.
CUTR
| $1.21M | ﹤0.01% |
33,708
-1,225
| -4% | -$41.4K |
|
3561
PUT
Healthpeak Properties
DOC
$14.3B
| $1.21M | ﹤0.01% |
+35,000
| New | +$1.22M |
|
3562
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $1.21M | ﹤0.01% |
23,019
+1,793
| +8% | +$93.9K |
|
|
NWLI
3563
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.21M | ﹤0.01% |
4,140
+3,175
| +329% | +$851K |
|
3564
Option Care Health
OPCH
$3.61B
| $1.2M | ﹤0.01% |
80,720
+70,099
| +660% | +$948K |
|
3565
Citizens & Northern Corp
CZNC
$466M
| $1.2M | ﹤0.01% |
42,533
+9,351
| +28% | +$244K |
|
3566
Cass Information Systems
CASS
$750M
| $1.2M | ﹤0.01% |
20,711
+11,459
| +124% | +$642K |
|
3567
QCR Holdings
QCRH
$1.75B
| $1.2M | ﹤0.01% |
27,267
+22,429
| +464% | +$916K |
|
3568
PUT
Agios Pharmaceuticals
AGIO
$2B
| $1.19M | ﹤0.01% |
25,000
| – | – |
|
|
ESGR
3569
DELISTED
Enstar Group
ESGR
| $1.19M | ﹤0.01% |
5,770
+1,591
| +38% | +$318K |
|
3570
Vitamin Cottage Natural Grocers
NGVC
$646M
| $1.19M | ﹤0.01% |
120,913
+53,901
| +80% | +$495K |
|
|
ISBC
3571
CALL
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.19M | ﹤0.01% |
+100,000
| New | +$1.2M |
|
3572
CALL
America Movil
AMX
$69.8B
| $1.19M | ﹤0.01% |
74,400
+64,400
| +644% | +$1.01M |
|
|
AD
3573
Array Digital Infrastructure
AD
$3.09B
| $1.19M | ﹤0.01% |
32,824
-24,818
| -43% | -$870K |
|
3574
Regional Management Corp
RM
$301M
| $1.18M | ﹤0.01% |
39,413
+33,749
| +596% | +$1.02M |
|
3575
Dorman Products
DORM
$3.95B
| $1.18M | ﹤0.01% |
15,637
+1,333
| +9% | +$101K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.